Difference between revisions of "FedCloudBSIM2"
Jump to navigation
Jump to search
Line 3: | Line 3: | ||
{{FedCloudUseCases | | {{FedCloudUseCases | | ||
FCUC_Status = | FCUC_Status = Assessed| | ||
FCUC_StartDate = 17-03-2014 | | FCUC_StartDate = 17-03-2014 | | ||
FCUC_EndDate = | | FCUC_EndDate = | | ||
Line 10: | Line 10: | ||
FCUC_ShortDesc = | FCUC_ShortDesc = | ||
BSIM2 is a spin-off company founded in 2011 as the result of scientific work carried out at the University of Coimbra, in collaboration with the University of Leeds. For five years, the promoters assembled a suite of computational algorithms and workflows to conduct large-scale screenings and identify new amyloid inhibitors. The first product of the company’s portfolio is directed against a rare and fatal neurodegenerative disease. | |||
| | | |
Revision as of 18:27, 15 December 2014
General Information
- Status: Assessed
- Start Date: 17-03-2014
- End Date:
- EGI.eu contact: Nuno Ferreira / nuno.ferreira@egi.eu ; Diego Scardaci / diego.scardaci@egi.eu
- External contact: Bruno Victor / bruno.victor@bsimsquare.com ; Carlos Simões / carlos.simoes@bsimsquare.com
Short Description
BSIM2 is a spin-off company founded in 2011 as the result of scientific work carried out at the University of Coimbra, in collaboration with the University of Leeds. For five years, the promoters assembled a suite of computational algorithms and workflows to conduct large-scale screenings and identify new amyloid inhibitors. The first product of the company’s portfolio is directed against a rare and fatal neurodegenerative disease.